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Ineffectiveness of Livings Wills Focus of
Lawrence University Biomedical Ethics
Lecture
Posted on: January 3rd, 2005 by Rick Peterson

A University of Michigan medical school and Ann Arbor VA
research investigator argues that a staple of the American medical
culture – the living will – does not nor cannot work in the second
installment of Lawrence University’s four-part 2004-05 Edward F.
Mielke Lecture Series in Biomedical Ethics.
Angela Fagerlin presents “Pulling the Plug on Living Wills: How
Living Wills have Failed to Live up to Their Mandate,”
Wednesday, Jan. 12 at 7 p.m. in Lawrence’s Wriston Art Center
auditorium. The address, which will examine the shortcomings of
living wills as well as the use of durable power of attorney as an
alternative to living wills, is free and open to the public.
Living wills were originally created as a means of enabling an
individual to maintain a certain level of control at the end of their
life by detailing the types of treatment a person would like to
receive or measures they would like taken should they become
incapacitated and unable to make their own decisions. It is a
document widely recommended by experts, recognized by law in
nearly every state and one that hospitals are federally mandated to
inform their patients about.
But in a recently published research paper, Fagerlin and her
colleague Carl Schneider claim living wills consistently fail the
basic criteria necessary for them to be effective, thus giving them
little relevance in actual end-of-life decisions. According to
Fagerlin, among the problems with living wills is the inability of
most individuals to state their wishes accurately and
understandably and having the document available when treatment

decisions need to be made. The effectiveness of living wills, she
argues, is further compromised by advances in medical technology
and changes in an individual’s personal situation. The paper she
co-authored was based on a review of hundreds of living wills and
end-of-life decisions.
An internal medicine researcher in the University of Michigan
medical school’s Program for Improving Health Care Decisions
and the Ann Arbor Veteran’s Affairs Medical Center, Fagerlin
earned her Ph.D. in experimental psychology from Kent State
University. In addition to advanced directives and end-of-life
decisions, she has written articles on topics ranging from racial
differences in the treatment of prostate cancer to the use of
decision aids to facilitate patient involvement in their medical care.	
  

